Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Operating Leases (2019 - 2025)

Historic Operating Leases for Outlook Therapeutics (OTLK) over the last 4 years, with Q4 2025 value amounting to $171988.0.

  • Outlook Therapeutics' Operating Leases fell 2622.12% to $171988.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $171988.0, marking a year-over-year decrease of 2622.12%. This contributed to the annual value of $188801.0 for FY2025, which is N/A changed from last year.
  • Latest data reveals that Outlook Therapeutics reported Operating Leases of $171988.0 as of Q4 2025, which was down 2622.12% from $188801.0 recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Operating Leases ranged from a high of $233113.0 in Q4 2024 and a low of $171988.0 during Q4 2025